SMAD7 and cancer: By using in vitro, ex vivo, and in vivo models of CRC, we have previously shown that the knockdown of Smad7 with a specific Smad7 antisense oligonucleotide (AS) in CRC cells promoted endoplasmic reticulum stress, thereby inhibiting cancer growth.